Cargando...

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism

Patients with chronic kidney disease often develop secondary hyperparathyroidism (SHPT), marked by high levels of circulating parathyroid hormone (PTH) and increased risk of morbidity and mortality. Patients with SHPT are treated with a therapeutic combination that commonly includes calcimimetics, w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Apher Dial
Main Authors: Akizawa, Tadao, Ikejiri, Kazuaki, Kondo, Yuichiro, Endo, Yuichi, Fukagawa, Masafumi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7317959/
https://ncbi.nlm.nih.gov/pubmed/31486206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1744-9987.13434
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!